Cyclin-dependent kinase-3-mediated c-Jun phosphorylation at Ser63 and Ser73 enhances cell transformation

Yong-Yeon Cho1, Faqing Tang, Ke Yao

  • 1The Hormel Institute, University of Minnesota, 801 16th Avenue Northeast, Austin, MN 55912, USA.

Cancer Research
|January 2, 2009
PubMed

Insights

Cyclin-dependent kinase (Cdk) 3 phosphorylates c-Jun, a key component of the activator protein-1 (AP-1) complex. This Cdk3/c-Jun pathway is vital for epidermal growth factor (EGF)-stimulated cell proliferation and transformation.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Biochemistry

Background:

  • c-Jun is a critical component of the activator protein-1 (AP-1) complex.
  • AP-1 regulates gene expression, cell proliferation, transformation, and cancer development.

Purpose of the Study:

  • To identify novel kinases that phosphorylate c-Jun.
  • To investigate the role of cyclin-dependent kinase (Cdk) 3 in c-Jun activation and downstream signaling.

Main Methods:

  • In vitro and ex vivo kinase assays using Cdk3, Cdk2, and c-Jun NH(2)-terminal kinase.
  • Epidermal growth factor (EGF) stimulation of cells.
  • Analysis of AP-1 transactivation.
  • Ectopic expression of Cdk3 in JB6 Cl41 and NIH3T3 cells.

Main Results:

  • Cdk3, but not Cdk2 or c-Jun NH(2)-terminal kinase, was identified as a novel kinase of c-Jun.
  • Cdk3 phosphorylated c-Jun at Ser63 and Ser73.
  • EGF-induced Cdk3 activation led to c-Jun phosphorylation and enhanced AP-1 transactivation.
  • Ectopic Cdk3 expression promoted EGF-induced anchorage-independent cell transformation and Ras(G12V)-stimulated foci formation.

Conclusions:

  • The Cdk3/c-Jun signaling axis is a novel pathway involved in EGF-stimulated cell proliferation.
  • Cdk3 plays a significant role in EGF-induced cell transformation through AP-1 activation.

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
Positive Regulator Molecules01:45

Positive Regulator Molecules

To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...